Patents by Inventor Bernard Sebille

Bernard Sebille has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7682635
    Abstract: A composition comprises an aqueous dispersion of particles (p) of mean hydrodynamic diameter between 50 and 5000 nm. The particles contain (A) polymers based on cyclodextrin units, comprising on average at least four cyclodextrin units within their structure; and (B) macromolecules of polysaccharides comprising groups G capable of forming inclusion complexes with the cyclodextrins present in the structure of the polymers (A), with an average number of groups G per polysaccharide macromolecule at least equal to three. The compounds (A) and (B) are water-soluble in the isolated state. A method is also provided which relates to the preparation of these compositions, as well as their use in order to achieve the encapsulation of compounds such as active substances.
    Type: Grant
    Filed: July 1, 2003
    Date of Patent: March 23, 2010
    Assignees: Centre National de la Recherche Scientifique (C.N.R.S.), Universite de Paris 11 - Paris SUD
    Inventors: Ruxandra Gref, Catherine Amiel, Bernard Sebille, Patrick Couvreur
  • Publication number: 20050250881
    Abstract: The present invention relates to a composition comprising an aqueous dispersion of particles (p) of mean hydrodynamic diameter between 50 and 5000 nm, the said particles containing in association: (A) polymers based on cyclodextrin units, comprising on average at least 4 cyclodextrin units within their structure; and (B) macromolecules of polysaccharides comprising groups G capable of forming inclusion complexes with the cyclodextrins present in the structure of the said polymers (A), with an average number of groups G per polysaccharide macromolecule at least equal to 3, the said compounds (A) and (B) being water-soluble in the isolated state. The invention also relates to the method of preparation of these compositions, as well as their use in order to achieve the encapsulation of compounds such as active substances.
    Type: Application
    Filed: July 1, 2003
    Publication date: November 10, 2005
    Inventors: Ruxandra Gref, Catherine Amiel, Bernard Sebille, Patrick CouvreurV
  • Patent number: 5028395
    Abstract: Active chemical sensor with optical fiber and its production process.The chemical sensor according to the invention makes it possible to measure a given quantity or magnitude of a fluid. It has a chemical reagent suitable for the measurement and for reacting with the fluid, a support means (20a, 28) for the reagent and a single optical fiber (20) for supplying light to the reagent and recovering the light reflected by the reagent, said sensor being characterized in that the support means incorporates a vinyl imidazole polymer or copolymer film (28) in which the reagent is immobilized, said polymer being in particular directly grafted on to one of the ends (20a) of the optical fiber (20).
    Type: Grant
    Filed: July 16, 1990
    Date of Patent: July 2, 1991
    Assignees: Commissariat a l'Energie Atomique, Photonetics
    Inventors: Bernard Sebille, Bruno Biatry, Gilbert Boisde
  • Patent number: 4696937
    Abstract: The invention relates to novel thiosulfonate derivatives of general formu a:R--S--SO.sub.2 --R.sub.1in which R represents a 1H-imidazol-2-yl, quinolin-2-yl, 5-amino-1,3,4-thiadizol-2-yl or 4,5-dihydro-thiazol-2-yl radical and R.sub.1 represents a lower alkyl, (hydroxy)lower alkyl, phenyl, (lower alkyl) phenyl, (hydroxy lower alkyl) phenyl, (lower alkanoyl) phenyl or quinolin-8-yl radical.The thiosulfonate derivatives in question exert an inhibitory action with respect to the malformation or destruction of red blood corpuscules due to a genetic modification of haemoglobin or to parasites and can, therefore, be used in the treatment of drepanocytosis, malaria and babebiosis.
    Type: Grant
    Filed: November 13, 1985
    Date of Patent: September 29, 1987
    Assignees: Sanofi, Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Bernard Sebille, Yves Beuzard, Henri Demarne
  • Patent number: 4694015
    Abstract: The invention relates to pharmaceutical or veterinary compositions for initing the malformation or destruction of red blood corpuscules due to a genetic modification of haemoglobin or to parasites, compositions comprising, as active ingredient, at least one thiosulfonate derivative of general formula:R--S--SO.sub.2 --R.sub.1in which R represents a 1-methyl-imidazol-2-yl, 1H-benzimidazol-2-yl or benzoxazol-2-yl radical and R.sub.1 represents a lower alkyl, (hydroxy) lower alkyl, lower alkanoyl, phenyl, (lower alkyl) phenyl, (hydroxy lower alkyl) phenyl, (lower alkanoyl) phenyl or quinolin-8-yl radical.The compositions in question can be used in the treatment of drepanocytosis, malaria and babebiosis.
    Type: Grant
    Filed: November 13, 1985
    Date of Patent: September 15, 1987
    Assignees: Sanofi, Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Bernard Sebille, Yves Beuzard, Henri Demarne